Norwegian Fish Oil and Byproducts Producer Biomega Acquired by New York's AMERRA Capital
SEAFOODNEWS.COM [SeafoodNews] March 10, 2017
Agribusiness asset manager, AMERRA Capital Management has acquired more than 90 percent of Marine Bioproducts/Biomega (“Biomega”) based in Sotra, Norway. Biomega is a leading producer of high quality human grade peptones, proteins and oils derived from fresh fish by-products. Biomega collaborates with Alkymar, a provider of industrial enzymatic hydrolysis solutions with complementary technology and expertise. AMERRA intends to integrate the two companies.
Biomega was founded in 2001 with the purpose of conserving the nutritional value of by-products from the salmon farming industry. Biomega has developed technology applications for the premium pet foods and human nutrition market segments...
To Read Full Story Login Below.